Tekturna Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition:   HypertensionInterventions:   Drug: Aliskiren;   Drug: EnalaprilSponsor:   Novartis PharmaceuticalsRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition:   HypertensionInterventions:   Drug: Aliskiren;   Drug: EnalaprilSponsors:   Novartis;   Novartis PharmaceuticalsRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition:   HypertensionInterventions:   Drug: Aliskiren;   Drug: EnalaprilSponsors:   Novartis;   Novartis PharmaceuticalsRecruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition:   HypertensionInterventions:   Drug: Aliskiren;   Drug: EnalaprilSponsor:   Novartis PharmaceuticalsRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition:   HypertensionInterventions:   Drug: Aliskiren;   Drug: EnalaprilSponsors:   Novartis;   Novartis PharmaceuticalsRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials